Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets

Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets

  • September 2014
  • 122 pages
  • BCC Research
Report ID: 196578
An in-depth analysis of the global nucleic acid aptamer market by technologies, applications and geographic regional markets. This report includes key technologies involved, analyzes the capabilities and characteristics of aptamers in comparison with antibodies and lists specific areas where aptamers could find application. Forecasts are provided through 2019.

Use this report to:
- Define and identify key market segments and market structure in the nucleic acid aptamer market.
- Identify major stakeholders, product portfolios and recent developments, and draw a competitive landscape for market leaders.
- Focus exclusively on geographic segmentation. Analyze trends and opportunities in the major regions: North America, Europe, Asia-Pacific and the Rest of the World (ROW).
- Analyze the inclination of trends toward advanced aptamer technologies such as SELEX technologies and their scope in various applications.

Highlights
- The global market for nucleic acid aptamers reached $340.5 million in 2014. This market should grow to roughly $610.3 million in 2015 and about $5.4 billion in 2019, with a
compound annual growth rate (CAGR) of 73.5% from 2014 to 2019.
- The enabling technology market reached $200.9 million in 2014. This market should grow to $347.9 million in 2015 and $2.7 billion in 2019, with a compound annual growth rate (CAGR) of 68.5%.from 2014 to 2019.
- The diagnostic sensors market reached $139.6 million in 2014. This market should grow to about $262.4 million in 2015 and $2.6 billion in 2019, with a compound annual growth rate (CAGR) of 79.8% from 2014 to 2019.

Introduction & Scope

INTRODUCTION

STUDY GOALS AND OBJECTIVE
- Define and identify key market segments and market structure in the nucleic acid aptamer market.
- Measure and estimate the global nucleic acid aptamer market and its segments, including technology, applications and geographic regions.
- Identify key market dynamics and the factors impacting the global nucleic acid aptamer market and its subsegments.
- Identify the trends, gaps and opportunities in each of the micro markets.
- Focus exclusively on geographic segmentation. Analyze trends and opportunities in the major regions: North America, Europe, Asia-Pacific and the Rest of the World
(ROW).
- Identify major stakeholders, product portfolios and recent developments, and draw a competitive landscape for the market leaders.
- Evaluate key patents and clinical trials in aptamer technologies that are expecting early completion.
- Analyze emerging technologies such as aptasensors and fynomers and derive the opportunities available for these technologies.
- Analyze the inclination of trends toward advanced aptamer technologies such as SELEX technologies and their scope in various applications.

SCOPE OF THE REPORT
This research report presents an in-depth analysis of the global nucleic acid aptamer market by technologies, applications and geographic regional markets. It includes key
technologies involved, analyzes the capabilities and characteristics of aptamers in comparison with antibodies and lists specific areas where aptamers could find application. The evolving trends and technological developments in the field of aptamers have been studied in detail. Special emphasis will be given to collaborative efforts, research innovations and investment clinical trials conducted. Patents will be discussed as well. This study also analyzes the aptamer-based drugs that have been developed or are in the pipeline for the treatment of various diseases. Impact analysis of the key drivers and factors affecting or influencing the growth of this market is also included.

The market for aptamer technologies is further categorized into enabling technology, diagnostic sensors and therapeutics. Enabling technology consists of SELEX technology,
modified oligonucleotides, next-generation sequencing, nanoparticles and quantum dot labels, surface plasmon resonance and biolayer interferometry and bioinformatics. In terms of application the market is classified into diagnostics, therapeutics, research, biosensors, biomarker discovery and others. Furthermore, diagnostics-based aptamers are used in environmental monitoring and food and water safety. They are also used for developing aptasensors for sensing small molecules and pathogens. Aptamers also find application in human clinical diagnostic assays for diagnosing diseases such as cancer, infectious diseases and other immunological diseases.

Aptamers are used in therapeutics and research as drug delivery vehicles in cancer, as a modifier of surgical implants and in bioseparation processes. Research areas include
flow cytometry, mass spectrometry and Western blotting; they are also used as reagents and assays and as biosensors and biomarker molecules. The market is segmented by regions into North America, Europe, Asia-Pacific and ROW. Companies profiled in this report include Ophthotech Corp., Alimera Sciences, AM Biotechnologies LLC, Alnylam Pharmaceuticals, Noxxon, Rina Gmbh, Regado Biosciences, Base Pair Biotechnologies Inc., Aptamer Sciences Inc., Aptasol (Aptamer Solutions) Ltd, Isis Pharmaceuticals, Neoventures Biotechnology Inc., Mitsui & Co. (U.S.A.) Inc., Quest Diagnostics, SomaLogic Inc. and Sumitomo Bakelite Co. Ltd.
Country=World Industry=Biotechnology ParentIndustry=LifeSciences Date=201409 Topic=MarketReport Publisher=BCCResearch Price=5000